Lisa Bedell Clive

Bernstein’s Lisa Bedell Clive maintained a Market-Perform rating for DaVita HealthCare Partners Inc (NYSE: DVA), while reducing the price target from $74.50 to $71. DaVita reported its Q415 EPS 4 percent ahead of expectations. The company’s net income was in-line with the estimate,...